723 related articles for article (PubMed ID: 32098504)
1. Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy.
Ren Z; Yu P; Li D; Li Z; Liao Y; Wang Y; Zhou B; Wang L
Circulation; 2020 May; 141(21):1704-1719. PubMed ID: 32098504
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
[TBL] [Abstract][Full Text] [Related]
3. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
[TBL] [Abstract][Full Text] [Related]
4. Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy.
Su Q; Huang W; Huang Y; Dai R; Chang C; Li QY; Liu H; Li Z; Zhao Y; Wu Q; Pan DG
Cardiovasc Diabetol; 2024 Apr; 23(1):139. PubMed ID: 38664790
[TBL] [Abstract][Full Text] [Related]
5. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
6. A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction.
Chen S; Zhang Y; Lighthouse JK; Mickelsen DM; Wu J; Yao P; Small EM; Yan C
Circulation; 2020 Jan; 141(3):217-233. PubMed ID: 31801360
[TBL] [Abstract][Full Text] [Related]
7. ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling.
Koren L; Alishekevitz D; Elhanani O; Nevelsky A; Hai T; Kehat I; Shaked Y; Aronheim A
Int J Cardiol; 2015 Nov; 198():232-40. PubMed ID: 26201690
[TBL] [Abstract][Full Text] [Related]
8. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
9. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
10. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
Watson CJ; Horgan S; Neary R; Glezeva N; Tea I; Corrigan N; McDonald K; Ledwidge M; Baugh J
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):127-37. PubMed ID: 26130616
[TBL] [Abstract][Full Text] [Related]
12. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.
Liu X; Wu J; Zhu C; Liu J; Chen X; Zhuang T; Kuang Y; Wang Y; Hu H; Yu P; Fan H; Zhang Y; Liu Z; Zhang L
J Cell Mol Med; 2020 Jan; 24(2):2013-2026. PubMed ID: 31854513
[TBL] [Abstract][Full Text] [Related]
13. Repurposing an anti-cancer agent for the treatment of hypertrophic heart disease.
Dukinfield M; Maniati E; Reynolds LE; Aubdool A; Baliga RS; D'Amico G; Maiques O; Wang J; Bedi KC; Margulies KB; Sanz-Moreno V; Hobbs A; Hodivala-Dilke K
J Pathol; 2019 Dec; 249(4):523-535. PubMed ID: 31424556
[TBL] [Abstract][Full Text] [Related]
14. The cardiac maladaptive ATF3-dependent cross-talk between cardiomyocytes and macrophages is mediated by the IFNγ-CXCL10-CXCR3 axis.
Koren L; Barash U; Zohar Y; Karin N; Aronheim A
Int J Cardiol; 2017 Feb; 228():394-400. PubMed ID: 27870968
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and Cellular Diversity of the Human Heart.
Tucker NR; Chaffin M; Fleming SJ; Hall AW; Parsons VA; Bedi KC; Akkad AD; Herndon CN; Arduini A; Papangeli I; Roselli C; Aguet F; Choi SH; Ardlie KG; Babadi M; Margulies KB; Stegmann CM; Ellinor PT
Circulation; 2020 Aug; 142(5):466-482. PubMed ID: 32403949
[TBL] [Abstract][Full Text] [Related]
17. STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy.
Li PL; Liu H; Chen GP; Li L; Shi HJ; Nie HY; Liu Z; Hu YF; Yang J; Zhang P; Zhang XJ; She ZG; Li H; Huang Z; Zhu L
Hypertension; 2020 Oct; 76(4):1219-1230. PubMed ID: 32862709
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast GATA-4 and GATA-6 promote myocardial adaptation to pressure overload by enhancing cardiac angiogenesis.
Dittrich GM; Froese N; Wang X; Kroeger H; Wang H; Szaroszyk M; Malek-Mohammadi M; Cordero J; Keles M; Korf-Klingebiel M; Wollert KC; Geffers R; Mayr M; Conway SJ; Dobreva G; Bauersachs J; Heineke J
Basic Res Cardiol; 2021 Apr; 116(1):26. PubMed ID: 33876316
[TBL] [Abstract][Full Text] [Related]
19. Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy.
Cañes L; Martí-Pàmies I; Ballester-Servera C; Herraiz-Martínez A; Alonso J; Galán M; Nistal JF; Muniesa P; Osada J; Hove-Madsen L; Rodríguez C; Martínez-González J
Clin Sci (Lond); 2020 Feb; 134(3):359-377. PubMed ID: 31985010
[TBL] [Abstract][Full Text] [Related]
20. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
